Prospective study for clarification of mechanisms of acquired resistance for afatinib using plasma samples
Not Applicable
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000026108
- Lead Sponsor
- Saga Univ,Clinical research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
Not provided
Exclusion Criteria
1. Previously treated with an EGFR TKI. 2. Previously treated with an immune checkpoint inhibitor. 3. Patients who, in the opinion of the attending physician, are inappropriate for the study .
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method